borderline significancep = .08
The presence of BRAF mutation had trended to correlate only with younger age of patients, with borderline significance (median, 51.5 vs 56.5 years for BRAF + vs BRAF −; p = .08) (Table 1 ).
The presence of BRAF mutation had trended to correlate only with younger age of patients, with borderline significance (median, 51.5 vs 56.5 years for BRAF + vs BRAF −; p = .08) (Table 1 ).
There was also a trend for poorer survival in patients with extracapsular extension of nodal metastases, but it did not reach statistical significance (5-year OS rates, 47 vs 33.5 % for absence and presence of extracapsular involvement, respectively; p = .1).